Menopause and hormone replacement therapy: Focus groups of African-American and caucasian women

Menopause

Volumn 4, Issue 2, 1997, Pages 77-79

  Pham, Kim Thu C ^a   Freeman, Ellen W ^a   Grisso, Jeane Ann ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

African American; Caucasian; Hormone replacement therapy

Indexed keywords

EID: 0002955799     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann intern Med 1992;117:1016-36.
2. Hammond CB. Women’s concerns with hormone replacement therapy: compliance issues. Fertil Steril 1994;62(6 part 2): 1575-605.
3. Berman RS, Epstein R, Lydick EG. Compliance of women in tak-ing estrogen replacement therapy. J Womens Health 1996;5:213-20.
4. Rozenberg S, Vandromme J, Kroll M, Pastijn A, Liebens F. Compliance to hormone replacement therapy. Int J Fertil Menopause Stud 1995;40(suppl 1):23-32.
5. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses’ Health Study. N Engl J Med 1991;325:756-62.
6. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Framingham Study. N Engl J Med 1985:313:1038-43.
7. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.
8. Griffiths F, Convery B. Women’s use of hormone replacement therapy for relief of menopausal symptoms. for prevention of osteoporosis, and alter hysterectomy. Br J Gen Pract 1995:45: 355-8.
9. Fox-Young S, Sheehan M, O’Connor V, Cragg C, Del Mar C. Women’s perceptions and experience of menopause: a focus group study. J Psychosom Obstet Gynecol 1995;16:215-21.
10. Fox-Young S, Cragg C. Do psycho-social factors contribute more to symptom reporting by middle-aged women than hormonal status? Maturitas 1995;20:63-9.
11. Utian WH, Schiff I. NAMS-Gallup survey on women’s knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause J North Am Menopause Soc 1994; 1:39-48.
12. Leiblum SR, Swartzman LC. Women’s attitudes toward the menopause: an update. Maturitas 1986;8:47-56.
13. Groeneveld FPMJ, Bareman FP, Barentsen R, Dokter HJ, Drogendijk AC, Hoes AW. Relationships between attitude towards menopause. well-being and medical attention among women aged 45-60 years. Maturitas 1993;17:77-88.
14. Standing TS, Glazer G. Attitudes of low-income clinic patients toward menopause. Health Care Women Int 1992;13:271-80.
15. Derby CA, Hume AL, Barbour MM, McPhillips JB, Lasater TM, Carleton RA. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol 1993;137:1125-35.
16. Egeland GM, Matthews KA, Kuller LH, Kelsey SF. Characteristics of noncontraceptive hormone users. Prev Med 1988;17:403-22.
17. Pilote L, Hlatky MA. Attitudes of women toward hormone therapy and prevention of heart disease. Am Heart J 1995; 129:1237-8.
18. Logethetis ML. Women’s decisions about estrogen replacement therapy. West J Nurs Res 1991:13:458-74.